Related Experiment Video
Updated: Nov 2, 2025

06:35
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
18.1K
Resveratrol and endothelial function: A literature review
Negin Parsamanesh1, Arghavan Asghari2, Saeed Sardari3
1Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
Pharmacological Research
|June 13, 2021
Summary
Resveratrol (RSV), a compound from grapes, protects against endothelial dysfunction by targeting key molecular pathways. This review explores RSV
Area of Science:
- Cardiovascular Biology
- Molecular Pharmacology
- Nutraceutical Science
Background:
- Endothelial dysfunction is a critical factor in numerous diseases, including atherosclerosis, diabetes, and hypertension.
- It involves processes like impaired vasorelaxation, leukocyte adhesion, and senescence.
- Resveratrol (RSV) is a polyphenol with known bioactive properties.
Purpose of the Study:
- To review the pharmacological effects of Resveratrol (RSV) on endothelial function.
- To elucidate the molecular targets through which RSV exerts its protective effects.
- To assess the potential of RSV in managing endothelial dysfunction-associated disorders.
Main Methods:
- Literature review of experimental studies on Resveratrol and endothelial function.
- Analysis of molecular mechanisms and signaling pathways modulated by RSV.
- Synthesis of data on RSV's impact on various aspects of endothelial health.
Main Results:
- RSV modulates key events in endothelial dysfunction, including vasorelaxation and leukocyte adhesion.
- Its protective effects are mediated by diverse molecular targets such as SIRT1, AMPK, eNOS, Nrf2, PPAR, KLF2, and NF-kB.
- RSV demonstrates significant potential in addressing endothelial dysfunction.
Conclusions:
- Resveratrol exhibits significant endothelial protective effects.
- RSV targets multiple molecular pathways crucial for maintaining endothelial function.
- This phytochemical holds promise for therapeutic applications in endothelial dysfunction-related diseases.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Vascular Resistance
8.2K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
8.2K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
266
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
266
Atherosclerosis III: Management
87
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87

